These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30588126)

  • 1. Ceftriaxone-associated nephrolithiasis and gallstone in adults.
    Azarkar G; Birjand MM; Ehsanbakhsh A; Bijari B; Abedini MR; Ziaee M
    Drug Healthc Patient Saf; 2018; 10():103-108. PubMed ID: 30588126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone-associated nephrolithiasis in children.
    Fesharakinia A; Ehsanbakhsh AR; Ghorashadizadeh N
    Iran J Pediatr; 2013 Dec; 23(6):643-7. PubMed ID: 24910741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftriaxone associated nephrolithiasis: a prospective study in 284 children.
    Mohkam M; Karimi A; Gharib A; Daneshmand H; Khatami A; Ghojevand N; Sharifian M
    Pediatr Nephrol; 2007 May; 22(5):690-4. PubMed ID: 17226043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of nephrolithiasis occurrence in children receiving cefotriaxone.
    Youssef DM; Sherief LM; Sherbiny HS; ElAttar MY; Sheikh AR; Fawzy FM; Adham T
    Nephrology (Carlton); 2016 May; 21(5):432-7. PubMed ID: 26369807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research Progress of Mechanisms of Ceftriaxone Associated Nephrolithiasis.
    Wang S; Huang X; Xu Q; Xu T
    Mini Rev Med Chem; 2017; 17(17):1584-1587. PubMed ID: 27488586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children.
    Ustyol L; Bulut MD; Agengin K; Bala KA; Yavuz A; Bora A; Demiroren K; Dogan M
    Hum Exp Toxicol; 2017 Jun; 36(6):547-553. PubMed ID: 27402682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children.
    Avci Z; Koktener A; Uras N; Catal F; Karadag A; Tekin O; Degirmencioglu H; Baskin E
    Arch Dis Child; 2004 Nov; 89(11):1069-72. PubMed ID: 15499067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.
    Clay PG; Graham MR; Lindsey CC; Lamp KC; Freeman C; Glaros A
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone-associated biliary pseudolithiasis in children.
    Biner B; Oner N; Celtik C; Bostancioğlu M; Tunçbilek N; Güzel A; Karasalihoğlu S
    J Clin Ultrasound; 2006 Jun; 34(5):217-22. PubMed ID: 16673364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental verification of factors influencing calcium salt formation based on a survey of the development of ceftriaxone-induced gallstone-related disorder.
    Ito R; Yoshida A; Taguchi K; Enoki Y; Yokoyama Y; Matsumoto K
    J Infect Chemother; 2019 Dec; 25(12):972-978. PubMed ID: 31186195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between renal stone disease and cholesterol gallstones: the easy to believe and not hard to retrieve theory of the metabolic syndrome.
    Ahmed MH; Barakat S; Almobarak AO
    Ren Fail; 2014 Jul; 36(6):957-62. PubMed ID: 24678942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of the body mass index and calcium nephrolithiasis in adult population.
    Milicevic S; Bijelic R; Krivokuca V; Bojic M; Popovic-Pejicic S; Bojanic N
    Med Arch; 2013 Dec; 67(6):423-7. PubMed ID: 25568513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone Administration Associated with Lithiasis in Children: Guilty or Not? A Systematic Review.
    Louta A; Kanellopoulou A; Alexopoulou Prounia L; Filippas M; Tsami FF; Vlachodimitropoulos A; Vezakis A; Polydorou A; Georgopoulos I; Gkentzi D; Spyridakis I; Karatza A; Sinopidis X
    J Pers Med; 2023 Apr; 13(4):. PubMed ID: 37109057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographic, Chemical, and
    Jahantab MB; Safaripour AA; Hassanzadeh S; Yavari Barhaghtalab MJ
    Can J Gastroenterol Hepatol; 2021; 2021():3351352. PubMed ID: 34422710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections.
    Tsukagoshi S; Ishizawa K; Hirayanagi K; Nagamine S; Makioka K; Fujita Y; Ikeda Y
    Intern Med; 2017 Dec; 56(23):3189-3192. PubMed ID: 29021458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of ceftriaxone use compared to standard of therapy in methicillin susceptible staphylococcal aureus (MSSA) bloodstream infections.
    Patel UC; McKissic EL; Kasper D; Lentino JR; Pachucki CT; Lee T; Lopansri BK
    Int J Clin Pharm; 2014 Dec; 36(6):1282-9. PubMed ID: 25186790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between gallstone disease and gall bladder volume.
    Olokoba AB; Bojuwoye BJ; Olokoba LB; Wahab KW; Salami AK; Braimoh KT; Inikori AK
    Niger J Clin Pract; 2008 Jun; 11(2):89-93. PubMed ID: 18817045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective review of ceftriaxone versus levofloxacin for treatment of E. coli urinary tract infections.
    Wang SS; Ratliff PD; Judd WR
    Int J Clin Pharm; 2018 Feb; 40(1):143-149. PubMed ID: 29147962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalciuria following ceftriaxone a fact or myth.
    Azarfar A; Esmaeeli M; Ravanshad Y; Bagheri S; Khodashenas E; Ghane-Sharbaf F; Malaki M; Mohamadian AH
    J Renal Inj Prev; 2015; 4(3):101-3. PubMed ID: 26468483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonographic findings in ceftriaxone: associated biliary sludge and pseudolithiasis in children.
    Ozturk A; Kaya M; Zeyrek D; Ozturk E; Kat N; Ziylan SZ
    Acta Radiol; 2005 Feb; 46(1):112-6. PubMed ID: 15841750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.